Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 12, 2025 11:22 ET | Source: PRISM MarketView

PRISM MarketView Honors Mental Health Awareness Month with a Spotlight on Emerging Innovators

PRISM MarketView Honors Mental Health Awareness Month with a Spotlight on Emerging Innovators
May 09, 2025 10:12 ET | Source: Research and Markets

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025 by Company A-Z, Therapy Focus and Technology Type

Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025" has been added to ResearchAndMarkets.com's offering.This report contains a...
May 07, 2025 16:10 ET | Source: OncoCyte Corporation

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

Oncocyte to Release First Quarter 2025 Results on May 12, 2025
April 22, 2025 05:30 ET | Source: Lipella Pharmaceuticals Inc.

Lipella Reports Positive Phase 2a Results from Second LP-310 Cohort in Oral Lichen Planus; Final Data Expected Q2 2025

Lipella Reports Positive Phase 2a Results from Second LP-310 Cohort in Oral Lichen Planus; Final Data Expected Q2 2025
April 16, 2025 09:52 ET | Source: Research and Markets

Pharmaceuticals Licensing Deals Trends Report 2025 and Directory of Deals Signed Since 2019

Dublin, April 16, 2025 (GLOBE NEWSWIRE) -- The "Licensing Deals in Pharmaceuticals 2019-2025" report has been added to ResearchAndMarkets.com's offering.Licensing Deals in Pharmaceuticals provides...
April 15, 2025 10:36 ET | Source: PRISM MarketView

PRISM MarketView Spotlights Opus Genetics in New Q&A with CEO George Magrath

PRISM MarketView Spotlights Opus Genetics in New Q&A with CEO George Magrath
April 09, 2025 07:00 ET | Source: Aclarion, Inc.

Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub

Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub
April 08, 2025 05:00 ET | Source: Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus

Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus
April 02, 2025 08:45 ET | Source: OncoCyte Corporation

Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference

Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference
March 26, 2025 07:00 ET | Source: Aclarion, Inc.

Aclarion Announces Reverse Stock Split

Aclarion Announces Reverse Stock Split

Next Page keyboard_arrow_right